Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
2.590
-0.130 (-4.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Gelteq Employees
As of June 30, 2024, Gelteq had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$11,952
Profits / Employee
-$295,753
Market Cap
24.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 8 | 0 | - |
| Jun 30, 2023 | 8 | 5 | 166.67% |
| Jun 30, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HOOKIPA Pharma | 179 |
| Vivos Therapeutics | 123 |
| Adagio Medical Holdings | 85 |
| Femasys | 34 |
| Daré Bioscience | 26 |
| Longeveron | 24 |
| BriaCell Therapeutics | 16 |
| Akari Therapeutics, | 12 |
GELS News
- 4 days ago - Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug - GlobeNewsWire
- 12 days ago - Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference - GlobeNewsWire
- 19 days ago - Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand - GlobeNewsWire
- 25 days ago - Gelteq Announces 400,000 Units Enter into Production in November 2024 - GlobeNewsWire
- 5 weeks ago - Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business - GlobeNewsWire
- 7 weeks ago - Gelteq Limited Closes US$5.2 Million Initial Public Offering - GlobeNewsWire
- 7 weeks ago - Gelteq Limited Prices US$5.2 Million Initial Public Offering - GlobeNewsWire